Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
1244 Results Found
AHA Post-Acute Care Advocacy Alliance News Update - June 13, 2025
AHA Post-Acute Care Advocacy Alliance News Update - June 13, 2025
Advocacy Issue: 340B Drug Pricing Program
The 340B program has worked successfully for over 30 years to allow eligible providers to stretch limited federal resources to provide more comprehensive programs and services to more patients. This is exactly what Congress intended when it created the program in 1992.
ASHRAE/ASHE Guideline 43
ASHRAE/ASHE Guideline 43, Operations Guideline for Ventilation of Health Care Facilities is here to help health care organizations during times when operationally ventilation systems need to function outside of the design requirements.
Rural Hospitals at Risk: Cuts to Medicaid Would Further Threaten Access
The One Big Beautiful Bill Act (H.R. 1) would result in 1.8 million individuals in rural communities losing their Medicaid coverage by 2034. In addition, select Medicaid provisions in H.R. 1 would result in a $50.4 billion reduction in federal Medicaid spending on rural hospitals over 10 years.
Hospitals That Have Committed to the 340B Principles
To ensure good stewardship of the 340B program, hospitals participating in the program should structure hospital policies and practices to demonstrate their commitment. That demonstration of commitment includes sharing publicly how 340B savings are used to benefit the community, by, for example reaching more eligible patients and providing more comprehensive services for those in the community. The following hospitals have taken that commitment.
The 340B Drug Pricing Program
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs. Despite significant oversight from HRSA and the program’s proven record of decreasing government spending and expanding access to patient care, some want to scale it back or drastically reduce the benefits that eligible hospitals and their patients receive from the program.
Executive Orders and Federal Actions Tracker
The AHA is tracking the Executive Orders and Actions of the Trump White House that may be of interest to hospitals and health systems.
Regulatory Relief to Promote Domestic Production of Critical Medicines
Directs the Commissioner of the Food and Drug Administration to review and eliminate any duplicative or unnecessary requirements in regulations and guidance pertaining to the development of domestic pharmaceutical manufacturing within 180 days.
Unleashing Prosperity Through Deregulation
Requires agencies to identify at least 10 regulations to be repealed for each new regulation proposed or promulgated. Directs agencies to ensure total incremental cost of all new regulations for FY 2025, including repealed regulations, is less than $0.